Medicalia.org

by Internet Medical Society

Ceritinib: Capsules for oral administration

Healthcare providers recommend using Ceritinib in treating patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive. Ceritinib is a white to almost white, light yellow, or brown powder. It is a kinase inhibitor, and its capsules come in 150 mg to administer orally via the mouth. Ceritinib is the active ingredient in the capsule with inactive ingredients colloidal anhydrous silica, L-hydroxypropyl cellulose, magnesium stearate, microcrystalline cellulose, sodium starch glycolate, and hard gelatin capsule shells. The common side-effects of Ceritinib are increased thirst, urinating often, increased hunger, blurred vision, headaches, tiredness, trouble thinking or concentrating, and your breath smells like fruit. 

Ceritinib 150 mg is readily available from several generic medicine suppliers at an affordable price. For more information about Ceritinib, reach us on 18008891064.

Views: 2

Reply to This

Advertisement

Interested in advertising on Medicalia.org?

-------------------------

-------------------------

-------------------------

INTERNATIONAL ARCHIVES OF MEDICINE

Submit your manuscript

© 2022   Created by Network Admin.   Powered by

Badges  |  Report an Issue  |  Terms of Service